116 related articles for article (PubMed ID: 31000340)
21. Serum FGF21 increases with hepatic fat accumulation in pediatric onset intestinal failure.
Mutanen A; Heikkilä P; Lohi J; Raivio T; Jalanko H; Pakarinen MP
J Hepatol; 2014 Jan; 60(1):183-90. PubMed ID: 24021426
[TBL] [Abstract][Full Text] [Related]
22. Fat digestion using RELiZORB in children with short bowel syndrome who are dependent on parenteral nutrition: Protocol for a 90-day, phase 3, open labeled study.
Tsikis ST; Fligor SC; Mitchell PD; Hirsch TI; Carbeau S; First E; Loring G; Rudie C; Freedman SD; Martin CR; Gura KM; Puder M
PLoS One; 2023; 18(3):e0282248. PubMed ID: 36857339
[TBL] [Abstract][Full Text] [Related]
23. Taurine status and response to intravenous taurine supplementation in adults with short-bowel syndrome undergoing long-term parenteral nutrition: a pilot study.
Schneider SM; Joly F; Gehrardt MF; Badran AM; Myara A; Thuillier F; Coudray-Lucas C; Cynober L; Trivin F; Messing B
Br J Nutr; 2006 Aug; 96(2):365-70. PubMed ID: 16923232
[TBL] [Abstract][Full Text] [Related]
24. Farnesoid X Receptor Agonist Treatment Alters Bile Acid Metabolism but Exacerbates Liver Damage in a Piglet Model of Short-Bowel Syndrome.
Pereira-Fantini PM; Lapthorne S; Gahan CGM; Joyce SA; Charles J; Fuller PJ; Bines JE
Cell Mol Gastroenterol Hepatol; 2017 Jul; 4(1):65-74. PubMed ID: 28560290
[TBL] [Abstract][Full Text] [Related]
25. Effect of ursodeoxycholic acid on cholesterol absorption and metabolism in humans.
Woollett LA; Buckley DD; Yao L; Jones PJ; Granholm NA; Tolley EA; Heubi JE
J Lipid Res; 2003 May; 44(5):935-42. PubMed ID: 12611908
[TBL] [Abstract][Full Text] [Related]
26. Effects of pravastatin and ursodeoxycholic acid on cholesterol and bile acid metabolism in patients with cholesterol gallstones.
Okamoto S; Nakano K; Kosahara K; Kishinaka M; Oda H; Ichimiya H; Chijiiwa K; Kuroki S
J Gastroenterol; 1994 Feb; 29(1):47-55. PubMed ID: 8199696
[TBL] [Abstract][Full Text] [Related]
27. Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis.
Roda E; Mazzella G; Bazzoli F; Villanova N; Minutello A; Simoni P; Ronchi M; Poggi C; Festi D; Aldini R
Dig Dis Sci; 1989 Dec; 34(12 Suppl):52S-58S. PubMed ID: 2598768
[TBL] [Abstract][Full Text] [Related]
28. FXR agonist GW4064 improves liver and intestinal pathology and alters bile acid metabolism in rats undergoing small intestinal resection.
Cao Y; Xiao Y; Zhou K; Yan J; Wang P; Yan W; Cai W
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G108-G115. PubMed ID: 30920307
[TBL] [Abstract][Full Text] [Related]
29. Energy intake in short bowel syndrome: assessment by 24-h dietary recalls compared with the doubly labelled water method.
Fassini PG; Das SK; Pfrimer K; Suen VMM; Sérgio Marchini J; Ferriolli E
Br J Nutr; 2018 Jan; 119(2):196-201. PubMed ID: 29268807
[TBL] [Abstract][Full Text] [Related]
30. Are plasma citrulline and glutamine biomarkers of intestinal absorptive function in patients with short bowel syndrome?
Luo M; Fernández-Estívariz C; Manatunga AK; Bazargan N; Gu LH; Jones DP; Klapproth JM; Sitaraman SV; Leader LM; Galloway JR; Ziegler TR
JPEN J Parenter Enteral Nutr; 2007; 31(1):1-7. PubMed ID: 17202433
[TBL] [Abstract][Full Text] [Related]
31. The effect of diet on bile acid kinetics and biliary lipid secretion in gallstone patients treated with ursodeoxycholic acid.
Frenkiel PG; Lee DW; Cohen H; Gilmore CJ; Resser K; Bonorris GG; Marks JW; Schoenfield LJ
Am J Clin Nutr; 1986 Feb; 43(2):239-50. PubMed ID: 3004189
[TBL] [Abstract][Full Text] [Related]
32. Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease.
Pathil A; Mueller J; Warth A; Chamulitrat W; Stremmel W
Hepatology; 2012 May; 55(5):1369-78. PubMed ID: 22183915
[TBL] [Abstract][Full Text] [Related]
33. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
Nilsell K; Angelin B; Leijd B; Einarsson K
Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcomes of various pediatric short bowel syndrome in China.
Zhang T; Feng H; Cao Y; Tao Y; Lu L; Yan W; Li F; Wang Y; Cai W
Pediatr Surg Int; 2021 Apr; 37(4):495-502. PubMed ID: 33394086
[TBL] [Abstract][Full Text] [Related]
35. Ursodeoxycholic acid treatment in cholesterol gallstone disease: effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, biliary lipid composition, and plasma lipid levels.
Angelin B; Ewerth S; Einarsson K
J Lipid Res; 1983 Apr; 24(4):461-8. PubMed ID: 6854153
[TBL] [Abstract][Full Text] [Related]
36. Conjugated bile acid replacement therapy for short-bowel syndrome.
Gruy-Kapral C; Little KH; Fordtran JS; Meziere TL; Hagey LR; Hofmann AF
Gastroenterology; 1999 Jan; 116(1):15-21. PubMed ID: 9869597
[TBL] [Abstract][Full Text] [Related]
37. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.
Angsten G; Finkel Y; Lucas S; Kassa AM; Paulsson M; Lilja HE
JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):587-95. PubMed ID: 22275330
[TBL] [Abstract][Full Text] [Related]
38. Oral insulin supplementation in paediatric short bowel disease: a pilot observational study.
Shamir R; Kolacek S; Koletzko S; Tavori I; Bader D; Litmanovitz I; Flidel-Rimon O; Marks KA; Sukhotnik I; Shehadeh N
J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):108-11. PubMed ID: 19503001
[TBL] [Abstract][Full Text] [Related]
39. Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis: A Human Pilot Study.
Assis DN; Abdelghany O; Cai SY; Gossard AA; Eaton JE; Keach JC; Deng Y; Setchell KD; Ciarleglio M; Lindor KD; Boyer JL
J Clin Gastroenterol; 2017 Feb; 51(2):e11-e16. PubMed ID: 27428727
[TBL] [Abstract][Full Text] [Related]
40. Impact of Clinical Use of Parenteral Lipid Emulsions on Bile Acid Metabolism and Composition in Neonatal Piglets.
Lavallee CM; Lim DW; Wizzard PR; Mazurak VC; Mi S; Curtis JM; Willing BP; Yap JY; Wales PW; Turner JM
JPEN J Parenter Enteral Nutr; 2019 Jul; 43(5):668-676. PubMed ID: 30137679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
